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Infections of the mammary gland and decreased 
resistance to pathogens frequently cause severe 
clinical mastitis and are among the increasing 
health problems in dairy cows (Burvenich et al., 
1994; Vangroenweghe et al., 2002). One of the most 
prevalent pathogens that cause intramammary in-
fection (IMI) is Escherichia coli (Bradley, 2002), a 
Gram-negative bacterium. The lipopolysaccharides 
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ABSTRACT: The immune response in milk cells and the status of mammary tight junctions (TJ) in response to 
intramammary (IM) infusion of different doses of Escherichia coli lipopolysaccharide (LPS) was investigated. Experi-
ment I: Seven German Braunvieh cows were IM infused into one quarter with 1 µg (LPS-1) and 3 µg (LPS-3) of 
LPS, respectively, and the contralateral control quarter with saline (9 g/l; C). Milk samples were taken immediately 
before and 12, 24, 36, 48, 60, 84 and 108 h after infusion and analysed for somatic cell counts (SCC), lactose, sodium 
(Na) and chloride (Cl) ions, and electrical conductivity (EC). Milk cell mRNA expression of various inflammatory 
factors was quantified by real-time RT-PCR. Blood samples were taken immediately after milking for the analysis 
of leukocytes (WBC), polymorphonuclear neutrophils (PMN), Na and Cl. Milk SCC, lactose, Na, Cl and EC did 
not differ significantly between LPS-1 and C quarters after the challenge. In LPS-3 quarters SCC levels increased 
within the first 12 h, reached peak levels between 12 and 36 h (P ≤ 0.001) and decreased (P ≤ 0.05) thereafter to 
reach baseline at 108 hours. Lactose in LPS-3 quarters decreased (P ≤ 0.05) to a minimum at 24 h and increased 
slightly thereafter while EC, Na, and Cl increased transiently in response to LPS-3. WBC and PMN levels in both 
groups decreased numerically within 24 h after LPS administration. In LPS-1, WBC at 24, 48 and 108 h were 
significantly lower whereas in LPS-3 they were significantly higher than at time 0. TNFα-mRNA expression in 
both groups did not change in response to IM LPS-challenge. IL-1β-mRNA expression at 12, 24 and 36 h in LPS-1 
quarters increased significantly as compared to time 0. In LPS-3 quarters the mRNA expression values of all 
tested ILs increased significantly as compared to time 0 within 12 h after LPS-challenge. IL-1β-mRNA expres-
sion decreased (P ≤ 0.05) at 48 and 84 h in LPS quarters. IL-8 mRNA was significantly decreased at 84 h after 
challenge in LPS-3 quarters. COX-2-mRNA expression in LPS-1 quarters decreased significantly as compared to 
time 0 at 48, 84 and 108 h, with a minimum at 84 h (P ≤ 0.05). In LPS-3 quarters COX-2-mRNA levels increased 
(P ≤ 0.05) within 48 h after the LPS-challenge. Experiment II: Six cows (5 German Braunvieh, 1 Brown Swiss) were 
injected in one quarter with 100 µg LPS and in the contralateral quarter with saline (9 g/l; C). Mammary biopsy 
samples of both quarters were taken immediately before and at 3, 6, 9 and 12 h after infusion and mRNA expres-
sion of TJ proteins occludin (OCLN) and zonula occludens (ZO-) 1, 2 and 3 were quantified by real-time RT-PCR.     
OCLN-mRNA expression did not change in response to the IM infusion while that of ZO-1, ZO-2 and ZO-3 
decreased significantly within six hours. In conclusion, a dose of 1 µg LPS did not initiate a immune response 
in the mammary gland. Furthermore the dose of 100 µg of LPS enhanced TJ permeability by reducing TJ plaque 
proteins density.
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(LPS) located in the outer cell membrane of Gram-
negative bacteria are mainly responsible for many 
of the clinical signs (fever, pain, increasing somatic 
cells, loss of milk character) in coliform mastitis 
(Jain et al., 1978; Hill, 1981; Guidry et al., 1983; 
Pfaffl et al., 2003). In experimental intramammary 
challenge studies LPS has been used in amounts of 
up to 500 µg to induce mastitis and to study the in-
flammatory response in the bovine udder (Hoeben 
et al., 2000; Mehrzad et al., 2001; Van Oostveldt et 
al., 2002; Schmitz et al., 2004a).
The immune defence of the bovine udder is medi-
ated by milk somatic cells composed of macrophag-
es (M), polymorphonuclear neutrophils (PMN), 
lymphocytes and epithelial cells. The number of 
each cell population is based on the immunologi-
cal status of the udder. Burvenich et al. (1994), 
Paape et al. (2002) and Sarikaya et al. (2004) de-
scribed M as the predominant cell type in the milk 
of healthy udders. After being activated through a 
pathogen contact, M release PMN-recruiting cy-
tokines like tumor necrosis factor alpha (TNFα), 
interleukin-1beta (IL-1β), interleukin-6 (IL-6) and 
interleukin-8 (IL-8) as well as lipid mediators such 
as cyclooxygenase-2 (COX-2). Thus, PMN become 
the predominant cell type in mastitic milk (Kehrli 
and Shuster, 1994; Paape et al., 2002; Sarikaya et 
al., 2004).
During lactation, the mammary secretory epithe-
lium is separated from the interstitial fluid by the 
endothelium to prevent interdiffusion. This section-
ing is guaranteed by the tight junctions (TJ). TJ are 
apically situated in the junctional complex which 
surrounds each epithelial cell (Nguyen and Neville, 
1998; Schneeberger and Lynch, 2004). TJ are as-
sociated with transmembrane proteins such as oc-
cludin (OCLN) and cytoplasmatic plaque proteins 
like zonula occludens 1 to 3 (ZO-1, ZO-2, ZO-3) 
(Nguyen and Neville, 1998; Haskins et al., 1998). As 
dynamic structures in the mammary gland TJ are 
leaky during pregnancy and close around parturi-
tion to the impermeable state during the course 
of lactation (Nguyen and Neville, 1998). However, 
also during ongoing lactation TJ can become leaky 
due to milk stasis, during mastitis, and in response 
to high doses of oxytocin (Stelwagen et al., 1997; 
Nguyen and Neville, 1998).
The aim of this study was to investigate a possi-
ble local immune response initiated by intramam-
marily (im) infused LPS in doses of 1 and 3 µg, 
respectively. In addition, the influence of 100 µg im 
infused LPS on the status of TJ was investigated.
MATERIAL AND METHODS
Animals and husbandry
This study was approved by the responsible 
animal care and use committee (Regierung von 
Oberbayern, Munich, Germany).
The seven German Braunvieh cows used in 
Experiment I (a + b) were kept in a tethered barn. 
They were fed maize silage, hay and concentrate. 
Water was available ad libitum. Three cows were 
in their first, three in their second and one in its 
fifth lactation. Two animals were in an early stage of 
lactation (25–72 days), three were in mid lactation 
(155–168 days) and two in a late stage of lactation 
(315–487 days). All animals were free of clinical 
signs of mastitis. Only quarters whose milk sam-
ples were cultured negative for mastitis pathogens 
five days before the experiment were accepted for 
the study.
The six dairy cows used in Experiment II were in 
their first to fourth lactation and were free of clini-
cal udder health problems as described previously 
(Schmitz et al., 2004a). Only quarters with a SCC 
< 150 000 cells per ml and milk samples cultured 
negative for mastitis pathogens were accepted.
Experimental and laboratory procedures
Experiment I
On day one of the experiment the milk of the 
two selected quarters of every cow was collected 
in a quarter milker (GEMA – Bruno Gelle GmbH, 
Wangen, Germany) during routine machine milk-
ing. The mammary glands were cleaned and the 
teats were disinfected. Thereafter cows were in-
jected in one quarter with 1 µg (a) or 3 µg (b) 
Escherichia coli lipopolysaccharide (LPS; Serotype 
O26:B6, Nr. L 8274, Sigma Chem. Co., St. Louis, 
USA) diluted in 10 ml saline and with 10 ml of 
saline (9 g/l) in the control quarters (C). Further 
quarter milk samples were taken at 12, 24, 36, 48, 
60, 84 and 108 h after the injection during routine 
machine milkings. Blood samples for haemato-
logical analyses were taken together with the milk 
samples. One aliquot each was anti-coagulated by 
ethylenediaminetetraacetic acid (EDTA) for the 
analysis of leukocytes (WBC) and PMN. Another 
aliquot was taken without anticoagulans and was 
centrifuged for serum production to analyse serum Veterinarni Medicina, 52, 2007 (6): 231–244  Original Paper
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electrolytes. Rectal temperature was measured at 
6 h after the im injection.
Measurement of milk constituents
Milk lactose concentration and somatic cell counts 
(SCC) in every sample were analysed in the labora-
tory of the Milchprufring Bayern e.V. (Wolnzach, 
Germany), by using a MilkoScan 4500 analyser 
(FOSS Electrik, Hillerod, Denmark). Aliquots of 
each sample were frozen at –20°C immediately af-
ter sampling for the determination electrical con-
ductivity (EC), sodium (Na) and chloride (Cl) ion 
concentrations. Na and Cl in milk were measured 
by potentiometer determination with ion selec-
tive electrodes model 9811 and model 9617BN 
(pH/Ise Meter, Modell 720 Aplus, Orion Research, 
Beverly, MA, USA). EC was measured at 25°C us-
ing the LDM electrode from WTW (LDM 130, 
Wissenschaftlich-Technische Werkstatten GmbH, 
Weilheim, Germany).
Determination of blood parameters
Total and differential WBC were measured 
with ADVIA 120 (Bayer Diagnostics, Fernwald, 
Germany), and blood Na and Cl were determined 
with a MODULAR E170 (Roche Diagnostics 
GmbH, Mannheim, Germany) at Vet Med Labor 
GmbH (Ludwigsburg, Germany). Blood lactose was 
measured by an enzymatic method (R-Biopharm 
AG, Darmstadt, Germany).
Milk cell isolation
200 g of each quarter milk sample were cen-
trifuged to separate the cell pellet according to 
Sarikaya et al. (2004). After washing twice with PBS 
the pellet was resuspended in 500 µl peqGOLD 
TriFast™ (PEQLAB Biotechnologie GmbH, 91052 
Erlangen, Germany) for total RNA isolation.
RNA isolation
Total RNA was isolated using peqGOLD TriFast™ 
(PEQLAB  Biotechnologie  GmbH,  Erlangen, 
Germany) according to the manufacturer’s in-
struction. The optical density (OD) was deter-
mined at three different dilutions of the final RNA 
preparations at 260 nm, corrected by the 320 nm 
background absorption, in order to quantify the 
extracted RNA. RNA integrity was verified by the 
OD260/OD280 absorption ratio 1.6–1.8.
Oligonucleotide primers
All used primers for each reference or target gene 
were synthesized commercially (MWG Biotech, 
Ebersberg, Germany) using already published bovine 
specific primer sequences (Schmitz et al., 2004a). 
All primer information is listed in Table 1.
mRNA quantification by real-time RT-PCR
The quantitative analysis of the different PCR-
products was worked out on the Rotor-Gene 
3000 (Corbett Life Science, NSW 2137, Sydney, 
Australia) via one-step qRT-PCR. 3.8 µl of extracted 
mRNA solutions (15 ng/µl) were used. According 
to the manufacturers instruction 6.2 µl Master Mix 
(Super ScriptTM III Platinum SYBR® Green One-
Step qRT-PCR Kit, Invitrogen GmbH, Karlsruhe, 
Germany) was prepared including 5 µl 2 × SYBR® 
Green Reaction Mix, 0.2 µl SYBR® Green One-Step 
Enzyme Mix, 0.5 µl (10pM) forward primer and 
0.5 µl (10pM) reverse primer.
Crossing points (CP) were achieved by Rotor- 
Gene software 5.0. A normalisation of the tar-
get genes was performed with an endogenous 
standard. Therefore the expression levels of two 
reference genes glyceraldehyde-3-phosphatedehy-
drogenase (GAPDH) and Ubiquitin (UbQ) were 
measured. The relative mRNA levels were calcu-
lated by normalisation of the CP of the target gene 
to the mean CP of the two reference genes UbQ 
and GAPDH.
Experiment II
Cows were injected in one quarter with 100 µg 
LPS (Serotype O26:B6, Sigma Chem. Co., St. Louis, 
MO, USA) in 10 ml of saline and in the contralat-
eral quarter with 10 ml saline (9 g/l). Mammary 
biopsy samples of both quarters were taken im-
mediately before (0) and at 3, 6, 9 and 12 h after 
injection. Biopsies were taken by using a human 
Bard® Magnum™ Biopsy Instrument with a Bard® Original Paper  Veterinarni Medicina, 52, 2007 (6): 231–244
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Magnum® Core Tissue Biopsy Needle (12 g × 10 cm) 
(BARD Inc., Covington, Georgia, USA), a core of 
30 to 60 mg mammary tissue was extracted.
From the mammary biopsy samples total RNA 
was isolated. The synthesis of first strand comple-
mentary DNA (cDNA) was conducted with reverse 
transcriptase (MMLV-RT, Promega Corporation, 
Madison, WI, USA) and random hexamer primers 
(MBI Fermentas, St. Leon-Rot, Germany). RT-PCR 
in a LightCycler (Roche Diagnostics, Mannheim, 
Germany) accomplished the amplification of the 
target nucleic acids. Primer sequences on factors 
which have not been published before are shown 
in Table 1.
Table 1. Sequences of PCR primers ( for = forward; rev = reverse), PCR product length and EMBL accession num-
ber of the used nucleic acid sequences, as well as product specific Rotor-Gene 3000 (Corbett Life Science)1 and 
LightCycler (Roche Diagnostics)2 conditions, respectively
Primer Sequence (5' → 3') Length (bp) EMBL (access. no.) Annealing (temp. °C)
Experiment I (a + b)1
UbQ for
UbQ rev
AGA TCC AGG ATA AGG AAG GCA T
GCT CCA CCT CCA GGG TGA T
198 Z18245  60
GAPDH for
GAPDH rev
GTCTTCACTACCATGGAGAAGG
TCATGGATGACCTTGGCCAG
197 U85042 58
TNF-α for
TNF-α rev
TAA CAA GCC GGT AGC CCA CG
GCA AGG GCT CGG GAT GGC AGA
277 AF011926  64
COX-2 for
COX-2 rev
TCT TCC TCC TGT GCC TGA T
CTG AGT ATC TTT GAC TGT GG
358 AF031698  64
IL-1β for
IL-1β rev
TTC TCT CCA GCC AAC CTT CAT T
ATC TGC AGC TGG ATG TTT CCA T
198 M37211 60
IL-6 for
IL-6 rev
GCT GAA TCT TCC AAA AAT GGA GG
GCT TCA GGA TCT GGA TCA GTG
200 NM173923 60
IL-8 for
IL-8 rev
ATG ACT TCC AAG CTG GCT GTT G
TTG ATA AAT TTG GGG TGG AAA G
149 AF232704 60
Experiment II2
UbQ for
UbQ rev
AGA TCC AGG ATA AGG AAG GCA T
GCT CCA CCT CCA GGG TGA T
198 Z18245 62
GAPDH for
GAPDH rev
GTCTTCACTACCATGGAGAAGG
TCATGGATGACCTTGGCCAG
197 U85042 62
OCLN for
OCLN rev
CTG GAT CAG GGA ATA TCC ACC
ACT CTT CAC TTT CTT CTC TAT AGT
176
AJ313191
AJ313182
64
ZO-1 for
ZO-1 rev
AGA AGA TAG CCC TGC AGC CAA
CCT CTC CTT TGT TAA AAC TAA GTC
272
AJ313188
AJ313183
64
ZO-2 for
ZO-2 rev
GAC CAG ATT CTG AAG GTG AACACA
TCC TTC TCA CAT TCA AAG TGG CT
197
AJ313187
AJ313184
64
ZO-3 for
ZO-3 rev
AAC GAC GTG GGC ATC TTC GT
GTG CGG ATG TAG AAG GAG TC
251
AJ313186
AJ313185
64
UbQ = ubiquitin; GAPDH = glyceraldehyde-3-phosphatedehydrogenase; TNFα = tumor necrose factor alpha; COX-2 = 
cyclooxygenase-2; IL = interleukin; OCLN = occludin; ZO = zonula occludensVeterinarni Medicina, 52, 2007 (6): 231–244  Original Paper
235
Statistical analysis
Data are presented as means ± SEM. Differences 
between treated and control quarters were tested 
for significance (P ≤ 0.05) by analysis of variance, 
using the MIXED procedure of the SAS program. 
The MIXED model included the animal and the 
sample as class variables. Within each sample the 
treatment was the repeated term. The matrix struc-
ture Compound Symmetry was used. Because SCC 
values could not be assumed to be normally distrib-
uted they were logarithmised (log10) for statistical 
calculations.
RESuLTS
Experiment I
Milk composition
SCC in quarters treated with 1 µg LPS (LPS-1) 
showed no significant changes as compared to C 
after the infusion (Figure 1a), but LPS-1 quarter 
values at 36, 48 and 60 hours changed significantly 
compared to time 0. Also C quarter values at 24, 
36, 48 and 60 h changed (P < 0.05) as compared to 
time 0. In quarters treated with 3 µg LPS (LPS-3) 
SCC increased within the first 12 h to maximal lev-
els between 12 and 36 h (P < 0.001) and decreased 
(P < 0.05) thereafter by 84 hours. In LPS-3 quarters 
SCC from 12 to 84 h were significantly higher as 
compared to time 0. SCC reached baseline values 
at 108 h after LPS administration (Figure 1b).
Lactose concentration in milk of LPS-1 quarters 
decreased to a minimum at 48 h after injection and 
increased thereafter to baseline values until the end 
of the experiment (Figure 2a). Within C quarters 
lactose at 36 and 60 h decreased significantly as 
compared to time 0. The concentration of lactose in 
the LPS-3 quarters remained significantly decreased 
until 36 h but started their increase already at 24 h 
to reach baseline levels at 60 h (Figure 2b).
The course of EC values during the investigation 
in LPS-1 quarters was similar to values in C (Figure 
3a). Values in C quarters showed a significant in-
crease 36 h after the treatment which was signifi-
cantly different from values in LPS-1 quarters as 
well as compared to time 0. In LPS-3 quarters EC 
increased up to maximum values at 12 h (P < 0.05), 
remained significantly elevated as compared to C 
with a slight decrease until 36 h and decreased fur-
ther to baseline levels at 48 h (Figure 3b). Within 
LPS-3 quarters values at 12, 24 and 36 h increased 
significantly as compared to time 0.
As demonstrated in Table 2 the levels of Na and 
Cl in LPS-1 quarters did not increase significantly 
in response to LPS treatment. On the contrary in 
LPS-3 quarters (Table 2) Na levels increased (P < 
0.05) to maximum values from 12 to 36 hours. 
Within LPS-3 quarters values at 12, 24, 36 and 
60 h were significantly increased as compared to 
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time 0. Cl values in LPS-3 quarters increased to a 
maximum at 24 h (P < 0.05) after the infusion. Na 
and Cl values reached basal values at the end of 
the studied period.
Blood parameters
WBC. In the LPS-1 group WBC at 24, 48 and 
108 h after the LPS infusion decreased significantly 
as compared to time 0 (Table 2). The percentage of 
PMN in the LPS-1 group showed only a numeri-
cal decrease at 24 h but did not differ significantly 
during the course of the experiment.
WBC and PMN in the LPS-3 group showed a 
numerical decrease within 24 h after LPS infusion 
(Table 2). Thereafter the amount of WBC increased 
as compared to time 0 (P < 0.05) up to 60 hours. 
The percentage of PMN decreased numerically 
within 24 h and reached its minimum at 48 hours. 
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During the further course the percentage of PMN 
increased to maximum values at 84 h of the inves-
tigation and reached baseline levels at the end of 
the studied period.
Electrolytes. Na levels in the LPS-1 group de-
creased within 24 h, then increased as compared 
to time 0 (P < 0.05) to a maximum at 36 h and 
decreased thereafter to baseline levels (Table 2). 
However Cl values in the LPS-1 group decreased 
significantly (compared to time 0) at 24 h and reached 
its minimum at 36 hours. Thereafter Cl increased to 
baseline levels within the next 12 h and remained 
unchanged until the end of the studied period.
As shown in Table 2 Na and Cl levels in LPS-3 
quarters showed no response to LPS infusion, al-
beit Na values increased (P < 0.05 as compared to 
time 0) at 108 h and Cl levels were elevated (P < 0.05 
as compared to time 0) at 84 h, respectively.
Cytokines
The TNFα expression in LPS-1 and LPS-3 quar-
ters did not change in response to im LPS infusion 
(Table 3).
IL-1β expression levels at 12, 24 and 36 h in LPS-1 
quarters increased significantly as compared to 
time 0 (Table 3), but there were no significant dif-
ferences between LPS-1 and corresponding C quar-
ters after LPS treatment. In LPS-3 quarters IL-1β 
values increased to its maximum at 12 h (P < 0.05) 
after infusion. Thereafter IL-1β was decreased (P ≤ 
0.05) at 48 and 84 h as compared to C quarters. 
IL-1β expression levels in C quarter increased to 
a maximum (P < 0.05) as compared to time 0 at 
36 h (Table 3).
As demonstrated in Table 3 the expression of IL-6-
mRNA in LPS-1 quarters did not change in response 
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to im LPS infusion. In LPS-3 quarters IL-6 values 
increased to a maximum (P < 0.05) within 12 h after 
infusion and decreased thereafter (Table 3).
IL-8 did not change within LPS-1 or C quarters 
and was not different between quarters at any time 
after the LPS treatment (Table 3). Compared to 
time 0 IL-8-mRNA expression levels in LPS-3 quar-
ters increased (P < 0.05) to highest values at 12 h 
and decreased thereafter. The measurement at 84 h 
diminished significantly in comparison to C quar-
ters as well as compared to time 0 (Table 3).
COX-2 expression levels in LPS-1 quarters did not 
show significant differences within the 36 h of in-
vestigation, but thereafter diminished as compared 
to time 0 from 48 h (P < 0.05) to a minimum (P < 
0.0001) at 84 h and increased (P < 0.05) again up to 
108 hours. The minimum values at 84 h were also 
different (P < 0.05) from the corresponding COX-2 
levels in C quarters (Table 3). COX-2 in LPS-3 
quarters was significantly elevated at 48 hours and 
decreased thereafter (Table 3).
Experiment II
TJ proteins OCLN, ZO-1, ZO-2 and ZO-3 in mam-
mary biopsy samples are demonstrated in Figure 4. 
OCLN-mRNA expression did not change signifi-
cantly in response to the im infusion of 100 µg LPS 
or saline but there was a numerically elevated value 
at 9 h after infusion in the LPS quarters. ZO-1- and 
ZO-2-mRNA expression decreased within the first 
6 h after the infusion to their minimum (P < 0.05) 
and increased thereafter to baseline levels.
ZO-3-mRNA expression levels showed no sig-
nificant differences between LPS and C quarter, 
whereas expression levels at 3 and 6 h after LPS 
challenge diminished significantly as compared to 
time 0.
DISCuSSION
Former investigators (Vangroenweghe et al., 2004) 
showed that there are dose dependent changes in 
milk and blood parameters after im LPS adminis-
tration. This led to the hypothesis that there might 
be doses of LPS without any clinical outcome of 
inflammation but with stimulating effects on the 
mammary gland immune system. Consequently we 
analysed factors that were earlier described (Kehrli 
and Shuster, 1994; Sordillo and Streicher, 2002) to 
be involved in natural host defence of the bovine 
mammary gland against invading pathogens.
Experiment I
In Experiment I we investigated the dose depend-
ent changes in the milk and blood of seven cows 
after an im infusion with 1 µg and 3 µg of LPS, 
respectively.
SCC has been established as the generally used 
parameter for udder health management worldwide. 
Elevated SCC is an important signal of IMI with 
pathogens (O’Brien et al., 1999; Pfaffl et al., 2003). 
Because of the TJ disruption during IMI elevated 
SCC are associated with increasing amounts of milk 
electrolytes (Na and Cl) and consequently with aug-
mented EC levels (Stelwagen et al., 1997; Nguyen 
and Neville, 1998; Bruckmaier et al., 2004). Lactose, 
the disaccharide produced only by the mammary 
gland (Wheelock and Rook, 1966; Kuhn and Linzell, 
1970), is mainly responsible for osmolarity in milk 
because of its low molecular weight and is therefore 
the main determinant of the milk volume (Mielke, 
1986; Ontsouka et al., 2003). Therefore changes 
of lactose concentration might also be associated 
with leaky TJ and, therefore, the concentration of 
lactose is mostly in diametrical opposition to milk 
electrolyte levels (Bruckmaier et al., 2004). All in-
vestigated milk parameters (SCC, lactose, EC and 
the electrolytes Na and Cl) did not change in LPS-1 
quarters as compared to C quarters. Our finding 
of decreasing lactose levels in quarters treated 
with LPS-1 and C quarters might be due to a great 
variance amongst animals, but not in response to 
the treatment. This could mean that we found a 
LPS dosage that initiates no signs of mastitis but 
might enhance mammary gland immunity. But it 
could although mean that there were no signs of 
mastitis because the LPS was milked out before 
any reaction developed. These important matters 
will be discussed later. In contrast to LPS-1 quar-
ters, values of all evaluated parameters in the milk 
of LPS-3 quarters changed in response to the LPS 
infusion according to earlier studies (Bruckmaier 
et al., 1993, 2004; Lee et al., 2003).
During an IMI, WBC and mainly PMN are chem-
otactically activated by inflammatory mediators, 
e.g. cytokines, to migrate from peripheral blood 
into milk (Persson et al., 1993). This is related to 
decreasing numbers of WBC and PMN in blood 
after LPS-challenge (Schmitz et al., 2004a) and Veterinarni Medicina, 52, 2007 (6): 231–244  Original Paper
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increasing numbers of mainly PMN in the SCC of 
infected quarters (Burvenich et al., 1994; Paape et 
al., 2002). The same changes are expected in elec-
trolyte values that occur by interdiffusion through 
a leaky blood milk barrier (Stelwagen et al., 1997; 
Nguyen and Neville, 1998). During the course of in-
vestigation all evaluated blood parameters showed 
remarkable differences in LPS-1 quarters but not in 
LPS-3 quarters that were contrary to the expected 
results but maybe due to a wide range of individual 
variation amongst all animals.
Cytokine expression in milk cell mRNA
TNFα released by M is one of the proinflamma-
tory cytokines which is mainly responsible for the 
endotoxic shock in the acute phase of coliform mas-
titis (Sordillo and Streicher, 2002). It also enhances 
the recruitment of PMN from blood into the mam-
mary gland by its chemotactic activity and therefore 
plays a major role in defence against mastitis (Blum 
et al., 2000). Pfaffl et al. (2003) demonstrated that 
milk somatic cells were the major source for TNFα. 
Although it is previously documented that TNFα 
concentrations increase after im infusion of LPS 
(Blum et al., 2000), expression levels in LPS-1 as 
well as in LPS-3 quarters did not show any remark-
able increase in response to the LPS treatment. This 
finding is obviously due to the very low doses of 
LPS which did not initiate inflammation. Possibly, 
some transient changes could not be detected in 
our experimental design. Previous studies (Blum et 
al., 2000; Pfaffl et al., 2003; Schmitz et al., 2004b) 
found maximum expression levels of TNFα already 
between 2 and 4 h after the LPS challenge. Due to 
technical reasons no samples were available at this 
time in the present study.
Besides TNFα which enhances the acute phase in-
flammatory response, there are other mediators for 
the first host reaction to invading pathogens: IL-1β 
and IL-6 (Sordillo and Streicher, 2002; Prgomet et 
al., 2005), which are also released by M and act as 
PMN-recruiting chemoattractants (Burvenich et 
al., 1994; Riollet et al., 2000a; Paape et al., 2002). 
Our results of more significant changes of the IL-1β 
expression in the lower LPS dose may be due to a 
great variation amongst all animals and was not 
in response to the treatment. The results of a sig-
nificant increase to the controls in the expression 
of IL-6 in LPS-3 quarters seems to be in response 
to the LPS administration but is not in agreement 
with Prgomet et al. (2005) who found out that IL-6 
expression changes analogue to IL-1β levels. In our 
study IL-6 levels run according to IL-8 expression 
levels.
In mammary gland immune response IL-8 is 
responsible for the inflammation and triggers the 
IL-1 induced PMN recruitment. IL-8 itself is also 
a very powerful chemoattractant for the accumu-
lation of PMN at sites of inflammation (Riollet et 
al., 2000b; Sordillo and Streicher, 2002). Persson 
Waller et al. (2003) found that the induction and 
the release of IL-8 is independent from the presence 
of TNFα and IL-1β. Our findings of increasing IL-8 
expression levels in LPS-3 quarters 12 h after the 
LPS-challenge compared to C quarters are accord-
ing to Riollet et al. (2000b) but different from their 
results, IL-8 values in our study decreased immedi-
ately after the 12 h peak, which may be due to our 
very low dose of LPS. Cyclooxygenase-1 (COX-1) 
and COX-2 are the key enzymes in the synthesis of 
prostanoids i.e. prostaglandins, prostacyclins and 
thromboxans. COX-1 is expressed in nearly all tis-
sues and it is therefore called the “house-keeping” 
isoform. COX-2 synthesis is induced by cytokines 
and therefore it is the predominant enzyme at sites 
of inflammation (Mitchell et al., 1995; Wittmann et 
al., 2002; Pfaffl et al., 2003). Our findings in both 
groups showed no remarkable differences accord 
to the LPS administration, therefore we have to 
assume that the wide range of individual vari-
ance amongst all animals led to these unspecific 
results.
Experiment II
Numerous former investigators (Allen, 1990; 
Stelwagen et al., 1994, 1997; Nguyen and Neville, 
1998; Sloth et al., 2003; Bruckmaier and Meyer, 
2005) assumed that changes in TJ protein structure 
might be existent when SCC and EC levels in milk 
increased, lactose occurred in blood and a reduced 
milk yield can be observed. Consequently the in-
fluence of 100 µg im infused LPS on TJ proteins 
OCLN, ZO-1, ZO-2 and ZO-3 in mammary tissue 
samples was evaluated in order to find confirma-
tions for these suggestions. Earlier publications 
(Bruckmaier et al., 2004; Schmitz et al., 2004a; 
Bruckmaier and Meyer, 2005) had shown that the 
mRNA expression of various factors changed after 
the LPS-challenge in these mammary tissue sam-
ples, which were used in this study.Original Paper  Veterinarni Medicina, 52, 2007 (6): 231–244
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OCLN was defined to be a TJ associated trans-
membrane protein (Furuse et al., 1993; Nguyen and 
Neville, 1998). Fujimoto (1995) found that by using 
immuno freeze fracture electron microscopy that 
OCLN is embedded in intramembranous strands of 
the TJ. Wong and Gumbiner (1997) discovered that 
a synthetic peptide of OCLN is able to increase TJ 
permeability but Schneeberger and Lynch (2004) 
reported that the principal function of OCLN is 
yet to be determined, but suggested that OCLN is 
improbably involved in the configuration of ion-se-
lective pores in the TJ. In our study OCLN-mRNA 
expression showed only a numerical increase 9 h 
after the LPS-challenge, which might be due to 
the elevated TNFα levels (Schmitz et al., 2004a) in 
these tissue samples. According to Mankertz et al. 
(2000) who found out that the expression of OCLN 
is regulated by inflammatory cytokines like TNFα 
or interferon-γ. The cytoplasmatic plaque proteins 
ZO-1, ZO-2 and ZO-3 are members of the MAGUK 
(membrane-associated guanylate kinase homo-
logue) family and in contrast to other members of 
this group each consists of an acidic domain, a ba-
sic arginine-rich region and a proline-rich domain 
(Haskins et al., 1998; Wittchen et al., 1999; Itoh et 
al., 1999; Schneeberger and Lynch, 2004). All ZO 
proteins are able to bind directly to OCLN, where 
as ZO-2 and ZO-3 interacts with ZO-1 but not with 
each other (Haskins et al., 1998; Wittchen et al., 
1999; Schneeberger and Lynch, 2004). Wittchen et 
al. (1999) allocated the complexity of these protein-
protein interactions at the site of TJ to have func-
tional as well as regulatory effects. Our findings of 
decreasing (P ≤ 0.05) mRNA expression levels of 
ZO-1, ZO-2 and ZO-3, respectively, six hours after 
the LPS administration might be the expression of 
an increasing TJ permeability. These results might 
be explained by the protein-protein interaction 
theory of the Wittchen et al. (1999) group.
CONCLuSION
In conclusion, on the one hand it can be assumed 
that a dose of 1 µg im infused LPS does not induce 
clinical signs of inflammation in the mammary 
gland but unfortunately has also no clear enhanc-
ing effects to mammary gland immunity, whereas 
the dose of 3 µg im LPS causes signs of IMI. On the 
other hand the depression in TJ protein expression 
in vivo proves the presumption that during mastitis 
LPS and increased SCC causes loss of TJ integrity.
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